Particle.news

Download on the App Store

UZH Researchers Unveil Real-Time CRISPR Platform to Decode Cancer Cell Evolution

A groundbreaking study reveals how stress-induced DNA damage and polyploidy drive cancer cell diversity and therapy resistance, with AI integration poised to enhance future analysis.

Image

Overview

  • University of Zurich researchers developed a CRISPR-based live-cell imaging platform to track cancer cell behavior across generations in real time.
  • The study demonstrates that stress in mother cells causes heritable DNA damage and desynchronization in daughter cells, fueling long-term tumor diversity.
  • Distinct pathways to polyploidy—rereplication and endoreplication—were identified, each contributing uniquely to genomic instability and drug resistance.
  • Integration of single-cell transcriptomics and pharmacological experiments linked specific replication errors to stability outcomes, advancing understanding of tumor evolution.
  • Plans are underway to automate data analysis using AI, with a focus on developing therapies targeting polyploidy and DNA-damage response mechanisms.